It is the first time that the Ministry of Health has set up a Committee for establishing a new Education/Training System in Urology along with a Specialty Degree/ Certification Exam System. The Committee has taken into account the proposal that the Hellenic Urological Association had submitted and processed in the past. In addition, a new Law is coming to bring changes in Continuing Education/Training and Scientific Societies. So, what is changing in Urology Education & Training? What are the eligibility criteria for a candidate to take the exams and get the specialty degree?
There are young men with chronic prostatitis coming to the Urologist asking for help for erection problems. How is the diagnosis set when there are multiple causes? Do we treat all causes simultaneously? And, most importantly, in what way do we treat them?
Radical Prostatectomy is a difficult surgical procedure with many traps even for experienced surgeons. We will follow such a case trying to identify the most crucial signs and severe complications. Only a few Urologists have been trained in the management of postoperative complications.
Fistulae are a nightmare for the Surgeon. What should we try to avoid? How can we diagnose them transoperatively? What are the basic principles for treating them?
Many are the times that we suspect cancer and receive positive biopsies. Both the Urologist and the patient want to know how severe the cancer is, how fast it will progress, when it will relapse. When and how should the cancer be treated? There are already useful biomarkers but how useful are they? And when is it really worth using them?
In Uroschool, we have always emphasized the high significance of the physican-patient communication skills. During the last years, these skills have been wordwide recognized as equally essential as surgical skills. Therefore, let us get ready for an experiential seminar that will give us the opportunity to learn the crucial principles of the so-called “Soft Skills”.
BPH is the most common disease in hospitals upon which we have been thoroughly trained. However, there are still many questions that remain unanswered. We will see a difficult case that poses many therapeutic dilemmas.
The ‘Virtual patient’ session is among the participants’ most favorite parts of UroSchool. Under the Trainer’s guidance, we will all try to approach step by step a particularly difficult case. Lithiasis is a disease that concerns us all with regard to both its therapeutic treatment and postsurgical management.
What new is there in Functional Urology? Urinary disorders, BPH, Incontinence, Infertility and Erectile Dysfunction through the latest developments and considerations.
Suddenly the entire approach has totally changed. MRI has been introduced and used as a diagnostic tool before biopsy and not only. Multiparametric MRI has become an everyday tool for Urologists. Yet, what do we actually know about MRI? How well do we understand and interpret the PiRΑDS scoring system? The time has come to learn everything about the above imaging technologies.
Why isn’t one therapy enough? Why do multimodal therapies gain more and more ground in many types of cancer? How and when do they enter therapeutic protocols?
D. Mauri Are Multimodal Therapies more effective in Urologic Oncology?
A. Papatsoris The Philosophy of Multimodal Therapies
After 30 years of silence, here come the wonders of Immunotherapy for the treatment of urothelial cancer. But what do we actually know about the required checkpoints? Where is modern Immunotherapy based on? What do immunotherapeutic drugs actually offer?
There is usually no full treatment of urinary incontinence, but only reduction of symptoms. The patient suffers and the Urologist cannot resolve the problem. A difficult case poses many therapeutic dilemmas.
Much has changed in prostatic cancer and there are even more changes taking place that we may not be aware of. We will get to know these changes through a difficult case.
Oncology has been the most rapidly developing field of Urology during the last years. Important studies were published last year that changed the existing trends and considerations. Let us comment on them.
It seems that we have to reconsider the clinical practice of prostate biopsy. Transrectal biopsy has been losing ground. MRI has been well established as a diagnostic means while U/S scan (frequency of29Hz) has brought new diagnostic potential.
Why isn’t one therapy enough? Why do multimodal therapies gain more and more ground in many types of cancer? How and when do they enter therapeutic protocols?